Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam R Glassman

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 15, 2012
Evaluation of masking study participants to intravitreal injections in a randomized clinical trialAdam R Glassman, Cynthia R Stockdale, Roy W Beck, et al.
Ophthalmology|February 22, 2017
ReplyJohn A Wells, Adam R Glassman, Lee M Jampol, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspectiveAdam R Glassman, Roy W Beck, David J Browning, et al.
JAMA Ophthalmology|December 23, 2016
Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular EdemaFrederick L Ferris, Maureen G Maguire, Adam R Glassman, et al.
American Journal of Ophthalmology|March 13, 2021
Costs of Managing Diabetic Macular Edema With Good Visual Acuity With Aflibercept, Laser, or Observation: DRCR Retina Network Protocol VDavid W Hutton, Adam R Glassman, Joshua D Stein, et al.
Ophthalmology|March 25, 2017
ReplyJohn A Wells, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|October 7, 2016
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical TrialLee M Jampol, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|May 12, 2017
Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical TrialDavid W Hutton, Joshua D Stein, Neil M Bressler, et al.
Ophthalmology|January 21, 2014
Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathyJennifer I Lim, Adam R Glassman, Lloyd Paul Aiello, et al.
JAMA Ophthalmology|October 25, 2019
Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical TrialDavid W Hutton, Joshua D Stein, Adam R Glassman, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 15, 2012
Evaluation of masking study participants to intravitreal injections in a randomized clinical trialAdam R Glassman, Cynthia R Stockdale, Roy W Beck, et al.
Ophthalmology|February 22, 2017
ReplyJohn A Wells, Adam R Glassman, Lee M Jampol, et al.
Investigative Ophthalmology & Visual Science|June 21, 2008
Comparison of optical coherence tomography in diabetic macular edema, with and without reading center manual grading from a clinical trials perspectiveAdam R Glassman, Roy W Beck, David J Browning, et al.
JAMA Ophthalmology|December 23, 2016
Evaluating Effects of Switching Anti-Vascular Endothelial Growth Factor Drugs for Age-Related Macular Degeneration and Diabetic Macular EdemaFrederick L Ferris, Maureen G Maguire, Adam R Glassman, et al.
American Journal of Ophthalmology|March 13, 2021
Costs of Managing Diabetic Macular Edema With Good Visual Acuity With Aflibercept, Laser, or Observation: DRCR Retina Network Protocol VDavid W Hutton, Adam R Glassman, Joshua D Stein, et al.
Ophthalmology|March 25, 2017
ReplyJohn A Wells, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|October 7, 2016
Anti-Vascular Endothelial Growth Factor Comparative Effectiveness Trial for Diabetic Macular Edema: Additional Efficacy Post Hoc Analyses of a Randomized Clinical TrialLee M Jampol, Adam R Glassman, Neil M Bressler, et al.
JAMA Ophthalmology|May 12, 2017
Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical TrialDavid W Hutton, Joshua D Stein, Neil M Bressler, et al.
Ophthalmology|January 21, 2014
Collaborative retrospective macula society study of photodynamic therapy for chronic central serous chorioretinopathyJennifer I Lim, Adam R Glassman, Lloyd Paul Aiello, et al.
JAMA Ophthalmology|October 25, 2019
Five-Year Cost-effectiveness of Intravitreous Ranibizumab Therapy vs Panretinal Photocoagulation for Treating Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical TrialDavid W Hutton, Joshua D Stein, Adam R Glassman, et al.
Pageof 13